Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size, Status and Forecast 2021-2027

The global Contract Development and Manufacturing Organization (CDMO) Outsourcing market size is projected to reach US$ 159510 million by 2027, from US$ 79390 million in 2020, at a CAGR of 10.0% during 2021-2027.

The CDMO is an outsourcing contract established between a pharmaceutical company and a contract manufacturing business. It allows the partial or complete transfer of development and production of a product or a medical device. The contract manufacturers generally have a very wide range of services. The goal is to be able to provide global solutions to pharmaceutical companies, either on an ad hoc basis, or by offering a turnkey service of the product, including galenic and stability developments, marketing authorisation applications, purchases, production and regulatory affairs.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Contract Development and Manufacturing Organization (CDMO) Outsourcing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Contract Development and Manufacturing Organization (CDMO) Outsourcing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Contract Development and Manufacturing Organization (CDMO) Outsourcing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Contract Development and Manufacturing Organization (CDMO) Outsourcing market.

Contract Development and Manufacturing Organization (CDMO) Outsourcing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Contract Development and Manufacturing Organization (CDMO) Outsourcing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Market Segment by Type

• Small molecules
• Biologics

Market Segment by Application

• API
• Drug

Market Segment by Region

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

List of Key Market Players

• Aenova Holding
• Almac Group
• Catalent
• FAMAR Health Care Services
• FAREVA
• Lonza Group
• Recipharm
• Siegfried Holding
• The Lubrizol
• Thermo Fisher Scientific